IGDEC-25
M.R.P: – 82
IGDEC-25 contains the Nandrolone Decanoate Injection that is used for treating osteoporosis in postmenopausal women. Nandrolone is an anabolic steroid occurring naturally in the human body, albeit in small quantities. Nandrolone increases the production and urinary excretion of erythropoietin. It may also have a direct action on bone marrow. Nandrolone binds to the androgen receptor to a greater degree than testosterone, but due to its inability to act on the muscle in ways unmediated by the receptor, has a less overall effect on muscle growth. Nandrolone is an androgen receptor agonist. The drug is bound to the receptor complexes which allows it to enter the nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence the transcriptional activity of certain genes, producing the androgen effects.
Precautions For Nandrolone Decanoate Injection
Nandrolone Decanoate Injection should be injected under the supervision of the doctor or nurse. This is normally injected into the vein and after taking there are few precautions such as do not drive, do not drink and other heavy-duty. Monitor the blood pressure after getting this injection injected.
Side Effects Of Nandrolone Decanoate Injection
Nandrolone Decanoate Injection has many side effects but they disappear once the symptoms of osteoporosis are treated. Visit the doctor immediately if the patient has any serious side effects.
One of the top leading companies, Soigner Pharma has gained a reputable place in the pharma market through its quality products. The company is an ISO certified Nandrolone Decanoate manufacturer and supplier in India. Moreover, the company is backed by well qualified and experienced staff that puts every single effort into maintaining the services. The company also offers the PCD Pharma Franchise for Nandrolone Decanoate Injection along with various benefits. We manufacture the products as per the norms set by WHO and GMP.
PHARMACOLOGY
PHARMACODYNAMICS: Nandrolone is an anabolic steroid occurring naturally in the human body, albeit in small quantities. Nandrolone increases production and urinary excretion of erythropoietin. It may also have a direct action on bone marrow. Nandrolone binds to the androgen receptor to a greater degree than testosterone, but due to its inability to act on the muscle in ways unmediated by the receptor, has less overall effect on muscle growth. Nandrolone is an androgen receptor agonist. The drug bound to the receptor complexes which allows it to enter the nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects.
PHARMACOKINETICS:
Protein Binding: – 58%
Metabolism: – Nandrolone is unusual in that unlike most anabolic steroids, it is not broken down into the more reactive DHT by the enzyme 5?-reductase, but rather into a less effective product known as Dihydronandrolone.
INDICATIONS: For the treatment of refractory deficient red cell production anemias, breast carcinoma. Hereditary angioedema, antithrombin III deficiency, fibrinogen excess. Growth failure and Turner’s syndrome. It is also indicated in the prophylaxis of hereditary angioedema.
Brand Name | IGDEC-25 |
---|---|
Composition | NANDROLONE DECANOATE 25 MG |
Pack Size | 25 MG |